Service: New marketing authorisations (human medicines)

• How to write a strong Module 3 for a marketing authorisation application

  21.04.2026

  

• What does it take to enter the EU pharmaceutical market? Regulatory, supply chain and market access realities explained

  27.02.2026

  

• How companies developing human and veterinary medicines can benefit from SME status in the EU

  03.09.2025

  

• New marketing authorisations and lifecycle management for human medicines

  13.06.2025

  

• Global pharma company & Medfiles: cooperation in obtaining and maintaining marketing authorisations in the EU

  08.03.2024

  

• Six reasons to engage regulatory CMC experts in drug development at an early stage

  20.02.2024

  

• Marketing authorisation application processes efficiently under one roof – for all EU countries

  12.02.2024

  

• Free Guide: What you need to know about active substance registration strategy?

  12.01.2024

  

• Longer lifecycles call for better quality – changing your eCTD publisher might be the solution

  05.06.2023